Avian reovirus sigma C enhances the mucosal and systemic immune responses elicited by antigen-conjugated lactic acid bacteria

Vaccine

Volumn 30, Issue 33, 2012, Pages 5019-5029

  Lin, Kuan Hsun ^a   Hsu, Ai Ping ^a   Shien, Jui Hung ^a   Chang, Tien Jye ^a   Liao, Jiunn Wang ^b   Chen, Jeng Rung ^a   Lin, Chuen Fu ^a   Hsu, Wei Li ^c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b FISHERIES RESEARCH INSTITUTE   (Taiwan)

^c CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

IBV; LAB; M cells; Mucosal immunity; Reovirus; Sigma C; Spike protein

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN A; SIGMA C PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AVIAN INFECTIOUS BRONCHITIS VIRUS; AVIAN ORTHOREOVIRUS; BACTERIAL STRAIN; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENTEROCOCCUS FAECIUM; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREACTIVITY; LACTIC ACID BACTERIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; ENTEROCOCCUS FAECIUM; FEMALE; GENETIC VECTORS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; INFECTIOUS BRONCHITIS VIRUS; LUNG; MICE; MICE, INBRED BALB C; ORTHOREOVIRUS, AVIAN; SERUM; VACCINATION;

EID: 84862757727     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.043     Document Type: Article

References (45)

1. Neutra M.R., Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nature Reviews Immunology 2006, 6(February 2):148-158.
2. Mestecky J., Blumberg R., Kiyono H., McGhee J.R. Fundamental immunology 2003, 965-1020. Academic, San Diego. 5th ed. W.E. Paul (Ed.).
3. Iwasaki A. Mucosal dendritic cells. Annual Review of Immunology 2007, 25:381-418.
4. Medina E., Guzman C.A. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. Vaccine 2001, 19(February (13-14)):1573-1580.
5. Yuki Y., Kiyono H. New generation of mucosal adjuvants for the induction of protective immunity. Reviews in Medical Virology 2003, 13(September-October (5)):293-310.
6. Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nature Medicine 2005, 11(April (4 Suppl)):S45-S53.
7. Bermudez-Humaran L.G., Cortes-Perez N.G., Le Loir Y., Alcocer-Gonzalez J.M., Tamez-Guerra R.S., de Oca-Luna R.M., et al. An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. Journal of Medical Microbiology 2004, 53(May (Pt 5)):427-433.
8. Bermudez-Humaran L.G., Cortes-Perez N.G., Lefevre F., Guimaraes V., Rabot S., Alcocer-Gonzalez J.M., et al. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. Journal of Immunology 2005, 175(December (11)):7297-7302.
9. Lee J.S., Poo H., Han D.P., Hong S.P., Kim K., Cho M.W., et al. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. Journal of Virology 2006, 80(April (8)):4079-4087.
10. Cortes-Perez N.G., Azevedo V., Alcocer-Gonzalez J.M., Rodriguez-Padilla C., Tamez-Guerra R.S., Corthier G., et al. Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli. Journal of Drug Targeting 2005, 13(February (2)):89-98.
11. Cortes-Perez N.G., Lefevre F., Corthier G., Adel-Patient K., Langella P., Bermudez-Humaran L.G. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine 2007, 25(September (36)):6581-6588.
12. Mohamadzadeh M., Olson S., Kalina W.V., Ruthel G., Demmin G.L., Warfield K.L., et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(February (8)):2880-2885.
13. Vissers Y.M., Snel J., Zuurendonk P.F., Smit B.A., Wichers H.J., Savelkoul H.F. Differential effects of Lactobacillus acidophilus and Lactobacillus plantarum strains on cytokine induction in human peripheral blood mononuclear cells. FEMS Immunology & Medical Microbiology 2010, 59(June (1)):60-70.
14. Surono I.S., Koestomo F.P., Novitasari N., Zakaria F.R., Yulianasari Koesnandar Novel probiotic Enterococcus faecium IS-27526 supplementation increased total salivary sIgA level and bodyweight of pre-school children: A pilot study. Anaerobe 2011, 17(6):496-500.
15. Ditu, Chifiriuc L.-M., Bezirtzoglou M.C., Voltsi E.C., Bleotu C., Pelinescu D., et al. Modulation of virulence and antibiotic susceptibility of enteropathogenic Escherichia coli strains by Enterococcus faecium probiotic strain culture fractions. Anaerobe 2011, 17(6):448-451.
16. Bybee S.N., Scorza A.V., Lappin M.R. Effect of the probiotic enterococcus faecium SF68 on presence of diarrhea in cats and dogs housed in an animal shelter. Journal of Veterinary Internal Medicine 2011, 25(4):856-860.
17. Ogier J.-C., Serror P. Safety assessment of dairy microorganisms: The Enterococcus genus. International Journal of Food Microbiology 2008, 126(3):291-301.
18. Lai M.M., Cavanagh D. The molecular biology of coronaviruses. Advances in Virus Research 1997, 48:1-100.
19. Masters P.S. The molecular biology of coronaviruses. Advances in Virus Research 2006, 66:193-292.
20. Gallagher T.M., Buchmeier M.J. Coronavirus spike proteins in viral entry and pathogenesis. Virology 2001, 279(January (2)):371-374.
21. Meanger J., Wickramasinghe R., Enriquez C.E., Wilcox G.E. Immune response to avian reovirus in chickens and protection against experimental infection. Australian Veterinary Journal 1997, 75(June (6)):428-432.
22. Wickramasinghe R., Meanger J., Enriquez C.E., Wilcox G.E. Avian reovirus proteins associated with neutralization of virus infectivity. Virology 1993, 194(June (2)):688-696.
23. Guardado Calvo P., Fox G.C., Hermo Parrado X.L., Llamas-Saiz A.L., Costas C., Martinez-Costas J., et al. Structure of the carboxy-terminal receptor-binding domain of avian reovirus fibre sigmaC. Journal of Molecular Biology 2005, 354(November (1)):137-149.
24. Helander A., Silvey K.J., Mantis N.J., Hutchings A.B., Chandran K., Lucas W.T., et al. The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces. Journal of Virology 2003, 77(July (14)):7964-7977.
25. Mishra N., Tiwari S., Vaidya B., Agrawal G.P., Vyas S.P. Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B. Journal of Drug Targeting 2011, 19(January (1)):67-78.
26. Gupta P.N., Vyas S.P. Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization. Colloids and Surfaces B: Biointerfaces 2011, 82(January (1)):118-125.
27. Desvaux M., Dumas E., Chafsey I., Hebraud M. Protein cell surface display in Gram-positive bacteria: from single protein to macromolecular protein structure. FEMS Microbiology Letters 2006, 256(March (1)):1-15.
28. Raha A.R., Varma N.R., Yusoff K., Ross E., Foo H.L. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine. Applied Microbiology and Biotechnology 2005, 68(July (1)):75-81.
29. Ignjatovic J., Sapats S. Identification of previously unknown antigenic epitopes on the S and N proteins of avian infectious bronchitis virus. Archives of Virology 2005, 150(September (9)):1813-1831.
30. Bergeron Y., Ouellet N., Deslauriers A.M., Simard M., Olivier M., Bergeron M.G. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infection and Immunity 1998, 66(March (3)):912-922.
31. Havennar R., Husis J.H.J. The lactic acid bacteria 1992, Elsevier Press, London. B.J.B. Wood (Ed.).
32. Alander M., Korpela R., Saxelin M., Vilpponen-Salmela T., Mattila-Sandholm T., von Wright A. Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Letters in Applied Microbiology 1997, 24(May (5)):361-364.
33. Lin W.H., Hwang C.F., Chen L.W., Tsen H.Y. Viable counts, characteristic evaluation for commercial lactic acid bacteria products. Food Microbiology 2006, 23(February (1)):74-81.
34. Vesterlund S., Karp M., Salminen S., Ouwehand A.C. Staphylococcus aureus adheres to human intestinal mucus but can be displaced by certain lactic acid bacteria. Microbiology 2006, 152(June (6)):1819-1826.
35. Collado M.C., Meriluoto J., Salminen S. Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Letters in Applied Microbiology 2007, 45(4):454-460.
36. Lawson L.B., Norton E.B., Clements J.D. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity. Current Opinion in Immunology 2011, 23(June (3)):414-420.
37. Buist G., Karsens H., Nauta A., van Sinderen D., Venema G., Kok J. Autolysis of Lactococcus lactis caused by induced overproduction of its major autolysin, AcmA. Applied and Environmental Microbiology 1997, 63(July (7)):2722-2728.
38. Wu Y., Wang X., Csencsits K.L., Haddad A., Walters N., Pascual D.W. M cell-targeted DNA vaccination. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(July (16)):9318-9323.
39. Guardado-Calvo P., Fox G.C., Llamas-Saiz A.L., van Raaij M.J. Crystallographic structure of the α-helical triple coiled-coil domain of avian reovirus S1133 fibre. Journal of General Virology 2009, 90(March (3)):672-677.
40. Nash A.D., Lofthouse S.A., Barcham G.J., Jacobs H.J., Ashman K., Meeusen E.N.T., et al. Recombinant cytokines as immunological adjuvants. Immunology and Cell Biology 1993, 71(5):367-379.
41. Schijns V.E., Weining K.C., Nuijten P., Rijke E.O., Staeheli P. Immunoadjuvant activities of E. coli- and plasmid-expressed recombinant chicken IFN-alpha/beta, IFN-gamma and IL-1beta in 1-day- and 3-week-old chickens. Vaccine 2000, 18(April (20)):2147-2154.
42. Ramsay A., Husband A., Ramshaw I., Bao S., Matthaei K., Koehler G., et al. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994, 264(April (5158)):561-563.
43. Yan D., Zhou H.R., Brooks K.H., Pestka J.J. Potential role for IL-5 and IL-6 in enhanced IgA secretion by Peyer's patch cells isolated from mice acutely exposed to vomitoxin. Toxicology 1997, 122(September (1-2)):145-158.
44. Kim D.Y., Sato A., Fukuyama S., Sagara H., Nagatake T., Kong I.G., et al. The airway antigen sampling system: respiratory M cells as an alternative gateway for inhaled antigens. Journal of Immunology 2011, 186(April (7)):4253-4262.
45. Kurono Y., Yamamoto M., Fujihashi K., Kodama S., Suzuki M., Mogi G., et al. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity. Journal of Infectious Diseases 1999, 180(July (1)):122-132.